GeneDx Holdings Corp. (WGS)
Healthcare • Diagnostics & Research
StockNasdaqGSUnited StatesUS81663L2007
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by GeneDx Holdings Corp., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 10:38. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 22 Feb 2027 16:00 | 0.30 | — | — | Upcoming |
| 09 Nov 2026 16:00 | 0.07 | 0.28 | +284.3% | Beat |
| 03 Aug 2026 16:00 | -0.19 | 0.01 | +105.3% | Beat |
| 04 May 2026 16:00 | -0.02 | -0.28 | -1,407.8% | Miss |
| 23 Feb 2026 06:00 | 0.12 | 0.14 | +16.7% | Beat |
| 28 Oct 2025 06:00 | 0.42 | 0.49 | +15.9% | Beat |
| 29 Jul 2025 06:00 | 0.11 | 0.50 | +371.7% | Beat |
| 30 Apr 2025 06:00 | 0.09 | 0.27 | +215.2% | Beat |
| 18 Feb 2025 06:00 | 0.10 | 0.64 | +514.9% | Beat |
| 29 Oct 2024 08:00 | -0.21 | 0.04 | +120.2% | Beat |
| 30 Jul 2024 16:00 | -0.30 | -0.10 | +65.7% | Beat |
| 29 Apr 2024 16:00 | -0.67 | -0.33 | +51.1% | Beat |
| 20 Feb 2024 16:00 | -0.65 | -0.63 | +2.9% | Beat |
| 30 Oct 2023 16:00 | -1.31 | -0.82 | +37.4% | Beat |
| 08 Aug 2023 16:00 | -1.31 | -1.77 | -34.8% | Miss |
| 09 May 2023 16:00 | -1.48 | -2.90 | -96.2% | Miss |
| 14 Mar 2023 16:00 | -5.28 | -5.69 | -7.8% | Miss |
| 14 Nov 2022 08:00 | -5.28 | -6.65 | -26.0% | Miss |
| 15 Aug 2022 16:00 | -5.61 | -7.12 | -27.0% | Miss |
| 12 May 2022 16:00 | -9.24 | -8.84 | +4.3% | Beat |
| 14 Mar 2022 16:00 | -7.26 | -10.86 | -49.6% | Miss |
| 15 Nov 2021 16:00 | -5.28 | -16.06 | -204.2% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 427.5M | +40.0% | -21M | -4.9% | -0.73 | +62.4% | 14.3M |
| 2024 | 305.5M | +50.8% | -52.3M | -17.1% | -1.94 | +73.2% | -34M |
| 2023 | 202.6M | -13.7% | -175.8M | -86.8% | -7.23 | +86.5% | -185.9M |
| 2022 | 234.7M | — | -549M | -233.9% | -53.63 | — | -333.5M |
| 2021 | — | — | — | — | — | — | — |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 63.19 | 67.40 | 51.26 | 51.87 | -16.84% | 7,236,700 | |
| 02 Nov 2026 – 06 Nov 2026 | 69.15 | 71.11 | 58.74 | 62.37 | -9.69% | 4,449,800 | |
| 26 Oct 2026 – 30 Oct 2026 | 58.06 | 71.50 | 58.00 | 69.06 | +22.99% | 4,312,200 | |
| 19 Oct 2026 – 23 Oct 2026 | 64.99 | 71.53 | 55.00 | 56.15 | -11.73% | 5,162,000 | |
| 12 Oct 2026 – 16 Oct 2026 | 67.33 | 72.70 | 62.01 | 63.61 | -5.53% | 3,420,800 | |
| 05 Oct 2026 – 09 Oct 2026 | 73.35 | 79.68 | 64.50 | 67.33 | -7.88% | 3,470,400 | |
| 28 Sep 2026 – 02 Oct 2026 | 87.33 | 89.32 | 70.48 | 73.09 | -17.32% | 4,138,500 | |
| 21 Sep 2026 – 25 Sep 2026 | 101.30 | 102.21 | 83.10 | 88.40 | -12.56% | 5,521,700 | |
| 14 Sep 2026 – 18 Sep 2026 | 85.64 | 105.18 | 83.88 | 101.10 | +18.57% | 3,754,500 | |
| 08 Sep 2026 – 11 Sep 2026 | 85.31 | 88.84 | 82.00 | 85.26 | -0.84% | 1,962,700 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- GeneDx Holdings Corp. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 12 Nov 2026 18:27
- Who Is Paying For GeneDx's Cash Burn? (opens in a new tab) Trefis · 12 Nov 2026 17:44
- GeneDx to Participate in Upcoming Investor Conferences (opens in a new tab) 11 Nov 2026 21:05
- GeneDx (WGS) Stock Looks About Right After Fresh Sales Progress (opens in a new tab) Simply Wall St. · 11 Nov 2026 11:12
- Is GeneDx Holdings (WGS) Undervalued After Third Quarter 2026 Results? (opens in a new tab) Simply Wall St. · 11 Nov 2026 09:11
- Why GeneDx Holdings Stock Just Dropped 16.6% (opens in a new tab) Motley Fool · 10 Nov 2026 22:06
- GeneDx Holdings Corp. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 10 Nov 2026 13:30
- GeneDx Research Demonstrates Medical Actionability of Exome and Genome Sequencing Results in Large Real-World Study of More Than 300,000 Patients (opens in a new tab) 10 Nov 2026 13:30
- GeneDx To Present New Research At The National Society Of Genetic Counselors Conference, November 11-14; Data Show 62% Of Patients With Pathogenic Or Likely Pathogenic Findings Had Results Associated With Opportunities To Inform Medical Management (opens in a new tab) Benzinga · 10 Nov 2026 09:39
- Groupon Posts Downbeat Q3 Results, Joins GeneDx Holdings, Qualys And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session (opens in a new tab) Benzinga · 10 Nov 2026 09:02
- GeneDx (WGS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 10 Nov 2026 07:02
- GeneDx Holdings Corp (WGS) (Q3 2026) Earnings Call Highlights: Revenue Hits $123. ... (opens in a new tab) GuruFocus.com · 10 Nov 2026 05:10
- BTIG Maintains Buy on GeneDx Holdings, Lowers Price Target to $85 (opens in a new tab) Benzinga · 10 Nov 2026 04:46
- Sema4 Holdings Corp options imply 21.9% move in share price post-earnings (opens in a new tab) TipRanks · 10 Nov 2026 04:20
- GeneDx Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 10 Nov 2026 02:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 55.12 USD
- Market cap
- 1.6B
- Exchange
- NasdaqGS
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow WGS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.